Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cellsMikkel G. Terp, Henrik J. Ditzel|npj Precision Oncology|2021Cited by 46
Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomesMikkel G. Terp, Henrik J. Ditzel|Molecular Oncology|2021Cited by 7